Doc's Drug License Doomed: Expired State Permit Ends DEA Access
Published Date: 6/23/2025
Notice
Summary
Dr. William Thompson IV lost his DEA registration because he no longer has permission to handle controlled substances in California. He didn’t ask for a hearing, so the DEA officially revoked his registration as of late 2024. This means he can’t legally prescribe or manage controlled drugs anymore, affecting his medical practice and any related income.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Thompson
Dr. William Thompson IV's DEA Certificate of Registration No. FT3578082 is revoked effective July 23, 2025 because he is not licensed to practice medicine in California. As a result, he cannot legally prescribe, dispense, or handle controlled substances in California, which will affect his medical practice and any income tied to prescribing controlled drugs.
Pending Renewal and Application Denials
The DEA denied any pending applications by Dr. William Thompson IV to renew or modify Certificate of Registration No. FT3578082, as well as any other pending applications for additional registration in California. This prevents him from regaining DEA registration through those pending applications in California.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-11479, Applications for New Awards; American History and Civics Education National Activities-Seminars for America's Semiquincentennial
The Department of Education is offering new grants for 2025 to support fun and educational seminars about American history and civics, celebrating the 250th anniversary of the United States. Schools, educators, and organizations can apply to get funding to create exciting learning experiences. This is a great chance to bring history to life with some extra cash and a clear deadline to join the celebration!
Next: 2025-11481, Intent To Prepare the Bakersfield Field Office Oil and Gas Supplemental Environmental Impact Statement and Potential Resource Management Plan Amendment, California
The Bakersfield Field Office is updating its plan to manage oil and gas drilling on public lands in California. This means they’ll study how drilling affects the environment and might change rules to keep things safe and fair. Local communities, businesses, and nature lovers should get ready to share their thoughts soon, as this process will take some time and could impact future land use and jobs.